Ana Blasco

2.7k total citations
104 papers, 1.5k citations indexed

About

Ana Blasco is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ana Blasco has authored 104 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in Ana Blasco's work include Lung Cancer Treatments and Mutations (31 papers), Cancer Genomics and Diagnostics (15 papers) and Lung Cancer Research Studies (14 papers). Ana Blasco is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Cancer Genomics and Diagnostics (15 papers) and Lung Cancer Research Studies (14 papers). Ana Blasco collaborates with scholars based in Spain, Norway and France. Ana Blasco's co-authors include Carlos Camps, Rafael Sirera, Eloísa Jantus‐Lewintre, Silvia Calabuig‐Fariñas, R. Guijarro, Roy M. Bremnes, Rafael Rosell, José Javier Sánchez, Elena Sanmartín and Miguel Martorell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ana Blasco

97 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Blasco Spain 23 726 648 487 456 121 104 1.5k
Mireia Margelí Vila Spain 20 784 1.1× 416 0.6× 440 0.9× 485 1.1× 127 1.0× 94 1.4k
Alain Gelibter Italy 22 974 1.3× 574 0.9× 332 0.7× 333 0.7× 101 0.8× 100 1.4k
Haifeng Qin China 18 632 0.9× 557 0.9× 458 0.9× 396 0.9× 77 0.6× 77 1.3k
Gun Min Kim South Korea 18 785 1.1× 549 0.8× 260 0.5× 351 0.8× 136 1.1× 91 1.3k
Herbert Stoeger Austria 17 848 1.2× 281 0.4× 333 0.7× 464 1.0× 81 0.7× 33 1.3k
Ta‐Chung Chao Taiwan 22 724 1.0× 485 0.7× 317 0.7× 248 0.5× 266 2.2× 99 1.4k
Akinobu Yoshimura Japan 22 553 0.8× 695 1.1× 704 1.4× 235 0.5× 68 0.6× 69 1.5k
Laura Zanotti Italy 27 527 0.7× 341 0.5× 546 1.1× 352 0.8× 95 0.8× 76 1.9k
Gregory N. Gan United States 20 807 1.1× 954 1.5× 572 1.2× 239 0.5× 84 0.7× 60 1.8k

Countries citing papers authored by Ana Blasco

Since Specialization
Citations

This map shows the geographic impact of Ana Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Blasco more than expected).

Fields of papers citing papers by Ana Blasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Blasco. The network helps show where Ana Blasco may publish in the future.

Co-authorship network of co-authors of Ana Blasco

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Blasco. A scholar is included among the top collaborators of Ana Blasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Blasco. Ana Blasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rören, Alexandra, Laurent Gajny, Ana Blasco, et al.. (2024). Arm elevation involves changes in the whole spine: an exploratory study using EOS imaging. BMC Musculoskeletal Disorders. 25(1). 993–993.
2.
Torres‐Martínez, Susana, Silvia Calabuig‐Fariñas, Ester Munera-Maravilla, et al.. (2023). Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 24(24). 17587–17587. 2 indexed citations
3.
Torres‐Martínez, Susana, Silvia Calabuig‐Fariñas, Giulia Bertolini, et al.. (2023). Soluble galectin‐3 as a microenvironment‐relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma. Molecular Oncology. 18(1). 190–215. 3 indexed citations
4.
Durendez-Saez, E., Silvia Calabuig‐Fariñas, Susana Torres‐Martínez, et al.. (2022). Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer. Cancers. 14(13). 3216–3216. 11 indexed citations
5.
Aix, Santiago Ponce, Enric Carcereny, Joaquim Bosch‐Barrera, et al.. (2021). 160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I. Annals of Oncology. 32. S1450–S1450. 5 indexed citations
6.
Dong, Ning, Silvia Calabuig‐Fariñas, Ana Blasco, et al.. (2021). Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers. 13(12). 2950–2950. 17 indexed citations
7.
Dong, Ning, Giuseppe D’Auria, Mariana Reyes‐Prieto, et al.. (2021). Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers. 13(11). 2514–2514. 34 indexed citations
8.
Dómine, Manuel, Teresa Morán, Dolores Isla, et al.. (2020). SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019). Clinical & Translational Oncology. 22(2). 245–255. 40 indexed citations
9.
Calabuig‐Fariñas, Silvia, Antònia Obrador‐Hevia, Ana Blasco, et al.. (2020). dPCR application in liquid biopsies: divide and conquer. Expert Review of Molecular Diagnostics. 21(1). 3–15. 23 indexed citations
10.
Martin, Élise, et al.. (2020). 1871P Overcoming barriers in opioid-induced constipation management. Annals of Oncology. 31. S1067–S1067. 1 indexed citations
11.
Herreros‐Pomares, Alejandro, Silvia Calabuig‐Fariñas, Rut Lucas-Domínguez, et al.. (2019). Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer. Cell Death and Disease. 10(9). 660–660. 75 indexed citations
12.
Garde, J., Paloma Martín-Martorell, Carmen Salvador Coloma, et al.. (2018). Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients. Clinical & Translational Oncology. 20(8). 1072–1079. 46 indexed citations
13.
Martín-Moreno, Paloma Leticia, Carmen Salvador Coloma, Xabier Mielgo-Rubio, et al.. (2017). P3.02c-084 Predictive and Prognostic Clinical and Pathological Factors of Nivolumab Efficacy in Non-Small-Cell Lung Cancer (NSCLC) Patients. Journal of Thoracic Oncology. 12(1). S1328–S1329. 2 indexed citations
14.
Calabuig‐Fariñas, Silvia, Eloísa Jantus‐Lewintre, Clara Mayo‐de‐las‐Casas, et al.. (2016). 149P: The role of CTCs and cfDNA for diagnosis and monitoring of EGFR mutations in advanced NSCLC patients. Journal of Thoracic Oncology. 11(4). S123–S123. 1 indexed citations
15.
Sanmartín, Elena, Rafael Sirera, Ana Blasco, et al.. (2013). A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer. Annals of Surgical Oncology. 21(2). 612–620. 22 indexed citations
16.
Camps, Carlos, et al.. (2010). Farmacoeconomía y los costes de los medicamentos contra el cáncer. Farmacia Hospitalaria. 34. 12–15. 3 indexed citations
17.
Godes, María José, et al.. (2008). Estudio descriptivo sobre el recuerdo del paciente tras la comunicación del diagnóstico y del pronóstico en oncología. Complutensian Scientific Journals (Complutense University of Madrid). 4(1). 21–33. 1 indexed citations
18.
Molina‐Vila, Miguel Ángel, R. de las Peñas, Vicente Alberola, et al.. (2007). P2-087: Elevated levels of thioredoxin (Trx) in serum correlate with poor outcome in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p). Journal of Thoracic Oncology. 2(8). S525–S525. 1 indexed citations
19.
Godes, María José, et al.. (2006). Estudio descriptivo sobre el proceso de comunicar el diagnóstico y el pronóstico en oncología. SHILAP Revista de lepidopterología. 5 indexed citations
20.
Pérez, Jesús Sastre, Mario Muñoz, Luís Naval, Ana Blasco, & Francisco J. Díaz. (2003). Papillary carcinoma arising in lingual thyroid. Journal of Cranio-Maxillofacial Surgery. 31(3). 179–182. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mireia Margelí Vila Breakdown of academic impact, for papers by Alain Gelibter Breakdown of academic impact, for papers by Haifeng Qin Breakdown of academic impact, for papers by Gun Min Kim Breakdown of academic impact, for papers by Herbert Stoeger Breakdown of academic impact, for papers by Ta‐Chung Chao Breakdown of academic impact, for papers by Akinobu Yoshimura Breakdown of academic impact, for papers by Laura Zanotti Breakdown of academic impact, for papers by Gregory N. Gan
Rankless by CCL
2026